par Kaye, S B;Piccart-Gebhart, Martine
;Aapro, Matty;Kavanagh, J
Référence European journal of cancer, 31A Suppl 4, page (S14-S17)
Publication Publié, 1995
;Aapro, Matty;Kavanagh, JRéférence European journal of cancer, 31A Suppl 4, page (S14-S17)
Publication Publié, 1995
Article révisé par les pairs
| Titre: |
|
| Auteur: | Kaye, S B; Piccart-Gebhart, Martine; Aapro, Matty; Kavanagh, J |
| Informations sur la publication: | European journal of cancer, 31A Suppl 4, page (S14-S17) |
| Statut de publication: | Publié, 1995 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| Mots-clés: | docetaxel |
| iatrogenic disease | |
| ovarian neoplasms | |
| phase II clinical trials | |
| MeSH keywords: | Adult |
| Aged | |
| Antineoplastic Agents, Phytogenic -- therapeutic use | |
| Female | |
| Humans | |
| Middle Aged | |
| Ovarian Neoplasms -- drug therapy | |
| Paclitaxel -- analogs & derivatives | |
| Paclitaxel -- therapeutic use | |
| Taxoids | |
| Note générale: | Clinical Trial |
| Clinical Trial, Phase II | |
| Journal Article | |
| SCOPUS: ar.j | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0959-8049 |
| info:doi/10.1016/0959-8049(95)00361-L | |
| info:pii/095980499500361L | |
| info:scp/0028810460 | |
| info:pmid/7577099 |



